Skip to content

Medical-device intelligence

QLU: Anti-Factor Xa Activity Test System, Apixaban

FDA product code QLU: Anti-Factor Xa Activity Test System, Apixaban. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QLU
FDA device name
Anti-Factor Xa Activity Test System, Apixaban
Device class
2
Regulation number
864.7295
Medical specialty
Hematology
Review panel
HE

FDA definition

A heparin and direct oral factor Xa inhibitor drug test system is intended for the detection of heparin and direct oral factor Xa inhibitors in human specimens collected from patients taking heparin or direct oral factor Xa inhibitors. This device is intended to aid in the management of therapy in conjunction with other clinical and laboratory findings.
Explore hematology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

2 clearance records and 1 recall records in the covered releases, across 3 source company names and 1 product codes. Dated history runs from Aug 25, 2021 to Oct 10, 2024.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
QLU · Anti-Factor Xa Activity Test System, Apixaban21

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

3 matching records
Device / recordCompany in FDA recordSourceSource date
INNOVANCE Anti-Xa (OPPU05); INNOVANCE Apixaban Standards (OPPW05); INNOVANCE Apixaban Controls (OPPS05)K240315 · QLUSiemens Healthcare Diagnostics Products GmbH510(k)Oct 10, 2024FDA decision date
HemosIL Liquid Anti-XaK223187 · QLUInstrumentation Laboratory CO510(k)Jun 23, 2023FDA decision date
HemosIL Liquid Anti-Xa- automated chromogenic assay for in vitro diagnostic use by laboratory professionals in clinical laboratories. The assay p…Z-0150-2022 · QLUInstrumentation LaboratoryRecallOct 19, 2021FDA record creation date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗